5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), astrocytoma, IDH-mutant, grade 2, astrocytoma, IDH-mutant, grade 3, astrocytoma, IDH-mutant, grade 4, epithelial neoplasm, follicular lymphoma, glioblastoma, glioma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, neuroepithelial neoplasm, oligodendroglioma, primitive neuroectodermal tumorRecruitingPhase 32026-08-28NCT05303519
Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients(EASY-TIP)Dyssomnias, Sleep Disorders, Intrinsic, Sleeplessness, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorderNot yet recruitingPhase 42026-07-29NCT07733414
Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery IIEnhanced Recovery After Surgery (ERAS) Protocol; Frail Elderly; Lumbar Degenerative Disease; Prehabilitation; Spine DegenerationRecruitingNot applicable2026-07-27NCT07396077
Rehabilitation Exercise Against Complications in High-risk Elderly After Lumbar Fusion(REACH)Adjacent Segment Degeneration; Lumber Fusion; Multimodal RehabilitationRecruitingNot applicable2026-02-17NCT07396051
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the ElderlyFerric CarboxymaltoseRecruitingNot applicable2025-07-10NCT07057973